Cargando…

Can vitamin B6 alleviate the adverse reactions of quadruple anti-Helicobacter pylori regimen? : randomized controlled trial

BACKGROUND: Vitamin B6 is an essential water-soluble vitamin for humans. It is often used to prevent a variety of neuropathies, relieve vomiting, and relieve symptoms such as hand and foot neuritis. AIM: To evaluate whether vitamin B6 can alleviate the adverse reactions caused by the quadruple anti-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cui, Meng-Yan, Zhang, Meng-Jie, Jiang, Qiao-Li, Pei, Zhong-Mei, Cui, Zhen-Yu, Kang, Mei, Lu, Lun-Gen, Lu, Ying-Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494335/ https://www.ncbi.nlm.nih.gov/pubmed/37697258 http://dx.doi.org/10.1186/s12879-023-08571-8

Ejemplares similares

Comparison of quadruple and triple Furazolidone containing regimens on eradication of helicobacter pylori
por: Mokhtare, Marjan, et al.
Publicado: (2015)

The impact of Helicobacter pylori infection and eradication therapy containing minocycline and metronidazole on intestinal microbiota
por: Cui, Meng-Yan, et al.
Publicado: (2022)

Clarithromycin versus Gemifloxacin in Quadruple Therapeutic Regimens for Helicobacter Pylori Infection Eradication
por: Mansour-Ghanaei, Fariborz, et al.
Publicado: (2017)

Comparison of Azithromycin and Metronidazole in a Quadruple-Therapy Regimen for Helicobacter pylori Eradication in Dyspepsia
por: Agah, Shahram, et al.
Publicado: (2009)

Efficacy of a quadruple therapy regimen for Helicobacter pylori eradication after partial gastrectomy
por: Zhang, F., et al.
Publicado: (2016)

The Comparison of Levofloxacin- and Clarithromycin-Based Bismuth Quadruple Therapy Regimens in Helicobacter pylori Eradication
por: Arj, Abbas, et al.
Publicado: (2020)

Efficacy of a 14-day quadruple-therapy regimen for third-line Helicobacter pylori eradication
por: Huang, Hsiang Tso, et al.
Publicado: (2018)

Efficacy of a bismuth-based quadruple therapy regimen for Helicobacter pylori eradication in Saudi Arabia
por: Alsohaibani, Fahad, et al.
Publicado: (2020)

Application of Minocycline-Containing Bismuth Quadruple Therapies as First-Line Regimens in the Treatment of Helicobacter pylori
por: Zhang, Lingyun, et al.
Publicado: (2019)

Efficacy and safety of bismuth quadruple regimens containing tetracycline or furazolidone for initial eradication of Helicobacter pylori
por: Wang, Junxian, et al.
Publicado: (2021)

Corrigendum to “Application of Minocycline-Containing Bismuth Quadruple Therapies as First-Line Regimens in the Treatment of Helicobacter pylori”
por: Zhang, Lingyun, et al.
Publicado: (2021)

Levofloxacin+Tetracycline Quadruple Regimen for Eradication of Helicobacter pylori: A Multicenter Multinational Randomized Controlled Trial
por: Alavinejad, Pezhman, et al.
Publicado: (2023)

Factors Affect the Eradication Rate of Helicobacter pylori by Modified Quadruple Therapy: A Prospective Cohort Study
por: Lan, Qiao-Li, et al.
Publicado: (2022)

Comparison of Second-Line Quadruple Therapies with or without Bismuth for Helicobacter pylori Infection
por: Jheng, Guang-Hong, et al.
Publicado: (2015)

Levofloxacin-containing triple therapy versus bismuth-based quadruple therapy as regimens for second line anti- Helicobacter pylori
por: Seyyedmajidi, Mohamadreza, et al.
Publicado: (2019)

Effects of 14-days bismuth- and tetracycline-containing quadruple therapy with concomitant regimen for the first line Helicobacter pylori eradication
por: Kazemi Veysari, Arash, et al.
Publicado: (2023)

Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori
por: Gisbert, Javier P, et al.
Publicado: (2012)

Susceptibility-guided bismuth quadruple therapies for resistant Helicobacter pylori infections
por: Yang, Tiankuo, et al.
Publicado: (2020)

Effects of Clarithromycin-Containing Quadruple Therapy on Helicobacter Pylori Eradication after Nitroimidazole-Containing Quadruple Therapy Failure
por: Fakheri, Hafez, et al.
Publicado: (2016)

Clarithromycin vs. Gemifloxacin in Quadruple Therapy Regimens for Empiric Primary Treatment of Helicobacter pylori Infection: A Randomized Clinical Trial
por: Masoodi, Mohsen, et al.
Publicado: (2015)

Inefficacy of Triple Therapy and Comparison of Two Different Bismuth-containing Quadruple Regimens as a Firstline Treatment Option for Helicobacter pylori
por: Kekilli, Murat, et al.
Publicado: (2016)

Efficacy and safety of modified tetracycline dosing in a quadruple therapy for Helicobacter pylori: A retrospective single center study
por: Sun, Ying-Chao, et al.
Publicado: (2023)

Effect of gastric microbiota on quadruple Helicobacter pylori eradication therapy containing bismuth
por: Niu, Zhan-Yue, et al.
Publicado: (2021)

Which is the best choice for Helicobacter pylori eradication? Dual therapy or quadruple therapy?
por: Bacaksız, Elif Gram, et al.
Publicado: (2022)

Effects of Quadruple Therapy Combined with Probiotics on Helicobacter Pylori-Related Peptic Ulcer
por: Zhou, Ye, et al.
Publicado: (2022)

Treatment with compound Lactobacillus acidophilus followed by a tetracycline- and furazolidone-containing quadruple regimen as a rescue therapy for Helicobacter pylori infection
por: Liu, Airu, et al.
Publicado: (2020)

Comparison between Hybrid, Reverse Hybrid, and Non-Bismuth Levofloxacin Quadruple Regimens for Helicobacter Pylori Infection in Egypt: A Randomized Trial
por: Fathy El Sayed, Ayman, et al.
Publicado: (2021)

Sequential Therapy vs Quadruple Therapy for Helicobacter pylori Eradication in South West of Iran
por: Masjedizadeh, Abdol Rahim, et al.
Publicado: (2014)

Shifts in the Human Gut Microbiota Structure Caused by Quadruple Helicobacter pylori Eradication Therapy
por: Olekhnovich, Evgenii I., et al.
Publicado: (2019)

Second-line bismuth-containing quadruple therapy for Helicobacter pylori eradication and impact of diabetes
por: Kim, Sung Eun, et al.
Publicado: (2017)

Efficacy of two-week therapy with doxycycline-based quadruple regimen versus levofloxacin concomitant regimen for helicobacter pylori infection: a prospective single-center randomized controlled trial
por: Alhalabi, Marouf, et al.
Publicado: (2021)

Outcomes of furazolidone- and amoxicillin-based quadruple therapy for Helicobacter pylori infection and predictors of failed eradication
por: Zhang, Ya-Wen, et al.
Publicado: (2018)

The efficacy and safety of furazolidone-bismuth quadruple therapy for Helicobacter pylori eradication with or without probiotic supplementation
por: Noorbakhsh, Nafeh, et al.
Publicado: (2022)

Success of 14-day triple and quadruple therapy for the control of Helicobacter pylori infections in Kohat district
por: Shah, Syed Fahim, et al.
Publicado: (2022)

Bismuth-Based Quadruple Therapy for Clarithromycin-Resistant Helicobacter pylori Infection: Effectiveness and Cost-Efficiency
por: Lee, Moon Won, et al.
Publicado: (2022)

Hybrid Therapy Regimen for Helicobacter Pylori Eradication
por: Song, Zhi-Qiang, et al.
Publicado: (2016)

Adding diclofenac to Helicobacter pylori eradication regimen
por: Emami, Mohammad Hasan, et al.
Publicado: (2015)

Efficacy and safety of probiotic-supplemented bismuth quadruple therapy for the treatment of Helicobacter pylori infection: a systematic review and meta-analysis
por: Yao, Gaoyan, et al.
Publicado: (2023)

Vitamin C and Helicobacter pylori Infection: Current Knowledge and Future Prospects
por: Mei, Haixin, et al.
Publicado: (2018)

Efficacy of quadruple regimen with polaprezinc for gastric Helicobacter pylori infection eradication: protocol for a single-centre, single-blind, non-inferiority, randomised clinical trial
por: Wu, Dingkun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0jrkduqo3tf5b50049ms49bjf0